Hikma’s First-Half Profits Leap By A Quarter

As Sales Ahead By Almost A Tenth, Boosted By Injectables

Growth
Hikma saw upward trends in the first half of 2020 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business